Back to search

Article

Developing High-Yield and Safe Therapeutic EVs by Ablating Tissue Factor-Mediated Toxicity

2025-12-25

Abstract excerpt

The clinical translation of extracellular vesicles (EVs) as next-generation drug delivery vehicles is currently stalled by two interrelated challenges: the difficulty of manufacturing EVs at an industrial scale ("the yield problem") and the risks of toxicity associated with systemic administration of high doses ("the safety ceiling"). In this comprehensive study, we present a two-pronged genetic engineering strate...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
d0d5123c-52a2-5aac-b472-f80830db1238
DOI
10.64898/2025.12.25.696171
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Developing High-Yield and Safe Therapeutic EVs by Ablating Tissue Factor-Mediated ToxicityDOI 10.64898/2025.12.25.696171
Select a neighboring publication to make it the new centre.